...Good morning, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. Thank you very much for joining the 7th Gene Editing and Gene Therapy Summit at the Barclays. I would like to first take this opportunity to thank all the investors, companies, also, especially our event team and the corporate access team who made this event possible. With that, I would like to introduce our next presenting company, Solid. With us today, we have Bo Cumbo, President and Chief Executive Officer. We also have Kevin Tan, Chief Financial Officer. Thank you both for joining us today. Kevin Tan ...